Debate continues over prostate cancer screening in Europe

Links shared publicly online about this topic.

  • 1,230
    total visits

Debate continues over prostate cancer screening in Europe

news-medical.net

The European Association of Urology reiterated that it does not recommend a mass screening policy in Europe for men who are concerned over prostate cancer, a stance which reflects the position it issued last year regarding prostate cancer screening. "We don't believe that the time has come for mass screening," said EAU Secretary General.

View full resource at news-medical.net

Tags: Cancer, Cancer Prevention, Prostate Cancer, Prostate, Men's Health, Urology

  • Share

Most Recently Shared on April 19, 2010 at 8:58 am By:

prostatecancers News-Medical.Net

Prostate Cancer: Debate continues over prostate cancer screening in Europe: The European Association of Urology re... http://bit.ly/aIMwXK

2 years ago...

Answering Questions About the P.S.A. Test - NYTimes.com

well.blogs.nytimes.com — “News that an influential panel of experts is advising healthy men not to be screened for prostate cancer with a widely used test is certain to cause confusion and anxiety among men and their doctors, and reignites a debate about the benefits and risks of screening tests.View full resource at well.blogs.nytimes.com

  • View Related
  • Share

Most Recently Shared on October 7, 2011 at 1:16 am By:

Cleveland Clinic uses new prostate cancer screening test | cleveland.com

cleveland.com — “The Cleveland Clinic is the first hospital in Northeast Ohio to use the PCA3 test to screen for prostate cancer, as the debate over testing and aggressive treatment continues.View full resource at cleveland.com

  • View Related
  • Share

Most Recently Shared on July 20, 2010 at 12:32 pm By:

prostatecancer_ Prostate Cancer Support

Cleveland Clinic uses new prostate cancer screening test http://bit.ly/aDwarL

2 years ago...

Lancet: Prostate cancer screening cuts mortality; debate continues

healthimaging.com — “Prostate cancer mortality was reduced almost by half over a 14-year period in a randomized patient population following prostate-specific antigen screening, said the results of a study published online June 30 in the Lancet Oncology.View full resource at healthimaging.com

  • View Related
  • Share

Most Recently Shared on July 2, 2010 at 2:27 am By:

HealthImaging Health Imaging & IT Health Magazine

Lancet: Prostate cancer screening cuts mortality; debate continues http://ow.ly/17Y1VQ

2 years ago...

Advertisement